<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 290 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page289.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=290">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 290 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 290</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=290"><img src="../thumb/290.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.10                                                        2020-04 / 253
                               st
       min.150 mg once wkly. Childr.over 4 wks: Init.6 mg/kg on 1  day fol-  Tinea unguium: Adults:150 mg once wkly.x3-12 mnths until nail   Contraindications: Concom.cisapride, concom. terfenadine with
       low.by 3 mg/kg once dly.x2 wks.at least to low. likelihood of relapse.  completely replac.  multiple fluconazole dos.&gt;400 mg / day, monit.multiple dos.ther.in
                             st
       Oesophag.candidiasis: Adults: Init.200 mg on 1  day follow. by   Children:  ren.impairm., safety in pregn. & lactat.not est.
       100-200 mg dly.with dos.of upto 400 mg dly if no clinic.respons.aft.14   Safety & effic has not been est.in childr.for recur. vag.candidias./  Side effects: Hepatotoxic.incl.fatalit.prim.in pres. of ser.underly.
       days. Treat for min.3 wks. & x2 wks.aft.sympt.resolv. Childr. over 4   candida balanit./dermatomycos.  medic.condits., skin reacts.incl. exfoliat. cutan.rects., GI disturbs.,
                 st
       wks: Init.6 mg/kg on 1  day follow.by 3 mg/ kg once dly.with dos.of   Use in childr.4 wks.& younger: In 1st 2 wks.of life: Use same   rash, headache, hepat./ren.& haematolog.funct.disturbs.partic.in
       up to 12 mg/kg/ day accord. to pt.condit.& respons. Treat for min.3   mg/kg dos.as for older childr.but admin. every 72 hrs. Wks. 3-4:   pts. with ser.underly.dis.such as AIDS and Ca, exfoliat. skin disords.,
       wks. & x2 wks.aft.sympt.resolut.  Same dos.but every 48 hrs. Max.adult dos.(400 mg) should not be   seiz., bld.dyscras., alopec., CNS effs., allerg.reacts.incl.anaphylax.,
       Fung.infect.prophylax.in pts.receiv.cytotox. chemo-/radiat.  exceed. in childr.  hypercholesterolaem., hypertriglyceridaem., hypokalaem., polyruia,
       ther: Adults: 50-400 mg dly.bas. on risk profile. Commenc.ther.sev.  Contra-indications: Concom.cisapride, concom. terfenadine with   thirst, fem.sex.dysfunct., intermenst. bleed., leukorrh., menorrhag.,
       days bef. anticipat. neutropen & contin.x7 days aft. neutrophil count   multiple fluconazole dos.&gt;400 mg / day, multiple dos.ther.in ren.im-  fatig., malaise, rigors, flush., taste pervers., abnorm.vis.
       rises above 1000 cells per mm  Childr.over 4 wks: 3–12 mg/kg/day   pairm., pregn. & breastfeed.  Special precautions: Monit.liv.funct.& discont. if S&S of liv.dis.at-
                    3
       depend.on extent & durat.of neutropen.  Side-effects: GI disturbs., rash, headache, hepat. ren.& haema-  trib.to fluconazole develop., AIDS pts.more suscept.to cutan.reacts.,
       Vag.candidiasis: Adults: 150 mg as sngl.dos.  tolog.funct.disturbs.partic.in pts.with ser. underly.dis., CNS/psych.  imp.ren.funct., bleed. events report.with concom.warfar., incr.risk of
       Recurr.vag.candidias: Adults: 150 mg once mnthly. Indiv.durat.  effs., alopec., bld. dyscras., allerg.reacts.incl.anaphylax./angioed.,   theophyll.toxic., careful monit.of concom. terfenadine at fluconazole
       which range from 4-12 mnths.  hypertriglyceridaem., hypercholesterolaem., hypokalaem., polyruia,   dos.&lt;400 mg/ day, uveit. in pts.receiv.rifabutin, nephrotox.report.with
       Candida balanitis: Adults: 150 mg as sngl.dos.  thirst, intermenst.bleed., leukorrh., menorrhag., fem.sex.dysfunct.,   tracrolimus, concom.meds.metabol.by cytochrome P-450 system.
       Derm.infects.eg.tinea pedis, corporis, cruris and candida   flush., malaise, rigors, fatig., abnorm.vis., taste pervers.  Warnings:  Monit.pts.develop.abnorm.liv.funct. for more seri-
       infects: Adults: 150 mg once wkly. x2-4 wks. but up to 6 wks.  Warnings and special precautions: Monit.pts. develop.abnorm.  ous hepat.injur.
       for tinea pedis.              liv.funct. for more serious hepat. injur., careful.monit.pts.receiv.con-  Drug interactions: Prolongs prothromb.time in warfarin ther., incr.
       Tinea unguium: Adults: 150 mg once wkly.x3-12 mnths until nail   com.terfenadine at fluconazole dos.&lt;400 mg/day, monit.pts.with rash.   midazolam conc.partic.aft. oral fluconazole admin., prolongs ser.half-
       completely replac.            closely & discont.ther.if bullous les./ erythema multiforme develops,   life of oral sulphonylureas, cyclospor.conc.grad.incr.aft.ren. transplan-
       Contraindications: Concom.cisapride, pregn. & lactat., multiple   AIDS pts.more suscept.to cutan.reacts., IV infus.in pts.requir. Na /fluid   tat., multiple hydrochlorothiazide dos. incr.fluconazole plasma conc.,
                                                              +
       dos.ther.in ren.impairm., avoid concom. astemizole., other azole   restrict., imp.ren.funct., bleed.events report.with concom.warfar., incr.  phenytoin/rifabutin / tacrolimus plasma conc.incr., theophyll.clear.
       antifung.agent hypersens, co-admin. of terfenadine in pts.receiv.   risk of theophyll. toxic., uveit.in pts.receiv.rifabutin, nephrotox. re-  reduc., rifampicin reduc.fluconazole half-life, incr. zidovudine plasma
       dos. &gt; 400 mg/day             port.with tracrolimus, discont.ther.when pts.with syst. fung.infects.  conc., card.events incl.torsades de pointes with cisapride, incr.plasma
       Side effects: Ser.hepatotox.with fatalit., prurit., rashes, urticar.,   develop.bullous les./erythema multiforme, concom.meds.metab.by   conc.of meds. metabol.by cytochrome P-450 syst.
       angioed., dry skin, abnorm.odour, alopec., exfoliat.cutan.reacts., hy-  cytochrome P-450 syst
       persens.reacts. incl.anaphylax., bld.dyscras., hypercholesterolaem.,   Drug interactions: Prolongs prothromb.time in warfar.ther., prolongs   FLUZOL, Sandoz [P/S]
       hypertriglyceridaem., hypokalaem., CNS effs.incl.seiz., fatig., rigors,   ser.half-life of oral sulphonylureas, incr.midazolam conc.partic.aft. oral   Fluconazole.
       GI disturbs., taste pervers., thirst, polyruia, fem.sex. dysfunct., inter-  admin., cyclospor.conc.grad.incr.aft.ren. transplantat., multiple hydro-  Indications: Adults & childr: Cryptococ. meningit. & maint.ther.to
       menst.bleed., menorrhag., leukorrh., abnorm.vis., hyperton.  chlorothiazide dos. incr. plasma conc., phenytoin/rifabutin/tacrolimus   prev.cryptococ.dis. relapse in AIDS pts., system.candidias., oropharyn-
       Warnings and special precautions: AIDS pts. more suscept.to   plasma conc.incr., theophyll.clear.reduc., rifampicin reduc.plasma   geal & oesophag.candidias., fung.infect. prophylax. in pts.with malign.
       cutan.reacts., discont.if bull.les./ erythema multiforme dev., monit.liv.  conc., incr.zidovudine plasma conc., incr.terfenadine conc.follow.  predispos.to such infects.due to chemo & radiother.
       funct.periodic. in pts.receiv.contin.treat.&gt; 1 mnth./if pt.dev.S&S sug-  high dos. fluconazole assoc. with ECG abnormalit., card.arrhythm.  Adults: Ac/recurr.vag.candidiasis & prophylax.to reduc.recurr.in-
       gest.of liv.dysfunct., monit.theophyll.conc., monit. prothromb.time   with cisapride/terfenadine, incr.plasma conc.of meds.metabol.by   cid of vag.candidias., candidial balanitis, dermatomycos.incl.tinea
       in pts.receiv.warfarin, monit. terfenadine conc.closely if co-admin.,   cytochrome P-450 syst.  cruris, tinea corporis, tinea pedis, tinea unguium (onychomycosis)
       concom. nevirapine, congenit.malformat.with admin. dur. pregn.,   & derm. candida infects.
       excret.in breast milk, imp.ren. funct., fluid admin.in pts req.Na/fluid   FLUCORIC, Ranbaxy [P/S]  (S4) CAPS, [P/S], 36/20.2.2/0261, 0262, 0263
       restrict., hepat./ ren.& haematolog.funct.disturbs.partic.in pts. with   Fluconazole.  700597-001: 50 mg, 14, R277,83
       ser.underly.dis.such as AIDS and malign., monit. pts.develop.abnorm.  Indications: Adults & childr: Cryptococ.meningit. & maint.ther.to   700598-001: 150 mg, 1, R50,55
       liv.funct.for more serious hepat.injur., elderly  prev.cryptococ.dis.relapse in AIDS pts., system.candidias., orophar-  700601-001: 200 mg, 30, R623,52
       Drug interactions: Incr.plasma conc.of meds. metabol. by cyto-  yng.& oesophag. candidias., fung.infect.prophylax.in pts.with malign.   (S4) INFUS, [P/S]. 2 mg/ml. 37/20.2.2/0033
       chrome P-450 system, warfar. anticoag. effs.incr., plasma conc.of   predispos.to such infects.due to chemo & radiother.  701497-001: 100 ml, R82,45
       oral sulphonylureas /phenytoin/zidovudine/midazolam / triazolam/  (S4) CAPS, [P/S] 37/20.2.2/0114, 0117  Dosage: Cont.ther.requir.multipl.dos.treatm.until lab.tests & clinic.
       rifabutin/tacrolimus incr., theophyll. clear. decr., life threaten.card.  700131-001: 50 mg, 14, R148,43  paramet.indic.act.infect.subsid. Maint.ther.usually reqd.in AIDS pts.
       arrhythm.with cisapride, signific.rise in cyclospor.conc., hydrochloro-  700202-001: 200 mg, 28, R440,00  with cryptococc. meningit/recurr.oropharyng.candidias. Infus.may be
       thiazide incr.fluconazole plasma conc., rifampicin reduc.fluconazole   Dosage: Cont.ther.requir.multipl.dos.treatm.until lab.tests & clinic.  infus.at max.rate of 200 mg/hr.with compat.admin.fluid. Mix.with any
       plasma conc., nevirapine expos.incr.  paramet.indic.act.infect.subsid. Maint.ther.usually reqd.in AIDS pts.  other drugs not recomm.
                                                                  Cryptococ.meningit: Adults: 400 mg on 1st day, then 200 mg
       FLUCONAZOLE UNICORN 150 mg, (Unicorn) Sandoz [P/S]  with cryptococc. meningit/recurr.oropharyng.candidias.   dly x6-8 wks, may be incr. to 400 mg dly. depend.on clinic.respon.
       Fluconazole.                  Adults:                      To prevent.relapse in AIDS pts: 100-200 mg dly.follow.prim.course
                                     Cryptococ.meningit: Adults: 400 mg on 1st day, then 200 mg
       Indications: Adults & childr: Cryptococ. meningit. & maint.ther.to   System.candidias: Adults: 1st day 400 mg, then 200 mg dly. Dos.
       prev.cryptococ.dis. relapse in AIDS pts., system.candidias., oropharyn-  dly x6-8 wks, may be incr. to 400 mg dly.depend.on clinic.respon.   may be incr.to 400 mg dly.depend. on clinic. respons.which also de-
       geal & oesophag.candidias., fung.infect. prophylax.in pts.with malign.  To prevent.relapse in AIDS pts: 100-200 mg dly.follow.prim.course   termin.durat. Childr. over 4 wks: 6-12 mg/kg/ day depend.on sever-
       predispos.to such infects.due to chemo & radiother.  System.candidias: 1st day 400 mg, then 200 mg dly. Dos.may   ity & durat.bas.on clinic. respons.
       Adults: Ac/recurr.vag.candidiasis & prophylax.to reduc.recurr.in-  be incr.to 400 mg dly.depend.on clinic. respons.which also deter-  Oropharyngeal candidias: Adults: Recomm.dos: 50-100 mg once
       cid of vag.candidias., candidial balanitis, dermatomycos.incl.tinea   min.durat.  dly.x7-14 days/long.in sev. immunocompris. pts. To prev.relapse in
       cruris, tinea corporis, tinea pedis, tinea unguium (onychomycosis)   Oropharyngeal candidias: Recomm.dos: 50-100 mg once dly.x7-  AIDS pts. aft. full course prim.ther.admin.150 mg once wkly. Childr.
       & derm. candida infects.      14 days/long.in sev. immunocompris. pts. To prev.relapse in AIDS pts.   over 4 wks: Init 6 mg/kg on 1  day follow. by 3 mg/kg once dly. x2
                                                                               st
       (S4) CAPS, [P/S], 36/20.2.2/0265  aft. full course prim.ther.admin.150 mg once wkly.  wks.at least to low. likelihood of relapse.
                                                     st
       718565-001: 150 mg, 1, R47,48  Oesophag.candidiasis:  200 mg on 1  day follow. by 100-200 mg   Oesophag.candidiasis:  Adults: 200 mg on 1  day follow. by 100-
                                                                                      st
       Dosage: Cont.ther.requir.multipl.dos.treatm.until lab.tests & clinic.  once dly.with dos.of up to 400 mg dly accord.to pt.respons. Treat for   200 mg once dly.with dos.of up to 400 mg dly accord.to pt.respons.
       paramet.indic.act.infect.subsid. Maint.ther.usually reqd.in AIDS pts.  min.3 wks. & x2 wks.aft.sympt.resolut.  Treat for min.3 wks. & x2 wks.aft.sympt.resolut. Childr.over 4 wks:
       with cryptococc. meningit/recurr.oropharyng.candidias.   Candidias.prophylax: 50-400 mg once dly.bas. on risk profile. Pts.  Init 6 mg/kg on 1  day follow.by 3 mg/kg once dly.with dos.of up to
                                                                          st
       Cryptococ.meningit: Adults: 400 mg on 1st day, then 200 mg   at high risk of system.infect. i.e. those anticipat.to have profound/  12 mg/kg/day accord.to pt. respons. Treat for min.3 wks.& x2 wks.
       dly x6-8 wks, may be incr. to 400 mg dly.depend.on clinic.respon.   prolong. neutropen. have receiv.400 mg once dly. Commenc. ther.  aft. sympt. resolut.
       To prevent.relapse in AIDS pts: 100-200 mg dly.follow.prim.course   sev.days bef.anticipat.neutropen & contin.x7 days aft. neutrophil   Candidias.prophylax: Adults: 50-400 mg once dly. bas. on risk
       System.candidias: Adults: 1st day 400 mg, then 200 mg dly. Dos.  count rises above 1000 cells per mm . 3  profile. Pts.at high risk of system. infect. i.e. those anticipat.to have
       may be incr.to 400 mg dly.depend. on clinic.respons.which also deter-  Children: Do not exceed.max.adult dly dos. Admin. as sngl   profound/ prolong. neutropen.have receiv.400 mg once dly. Commenc.
       min.durat. Childr. over 4 wks: 6-12 mg/kg/ day depend.on severity   dly.dos.  ther.sev.days bef.anticipat.neutropen & contin. x7 days aft. neutrophil
                                                            st
       & durat.bas.on clinic. respons.  Oropharyngeal candidias: Load.dos: 6 mg/kg on 1  day follow.  count rises above 1000 cells per mm  Childr.over 4 wks: 3-12 mg/
                                                                                  3
       Oropharyngeal candidias: Adults: Recomm. dos: 50-100 mg once   by 3 mg/kg once dly. x2 wks.at least to low. likelihood of relapse.  kg dly. depend.on extent & durat.of induc.neutropen.
                                                    st
       dly.x7-14 days/long.in sev. immunocompris.pts. To prev.relapse in   Oesophag.candidias: 6 mg/kg on 1  day follow. by 3 mg/kg once   Vag.candidiasis: Adults: 150 mg as sngl.oral dose.
       AIDS pts. aft.full course prim.ther.admin.150 mg once wkly. Childr.  dly.with dos.of upto 12 mg/kg/ day accord.to pt.respons. Treat for   Reduc.incid.of recurr.vag.candidias: Adults: 150 mg once
       over 4 wks: Init 6 mg/kg on 1  day follow. by 3 mg/kg once dly. x2   min.3 wks.& x2 wks.aft.sympt.resolut.  monthly indiv.durat.which range from 4-12 mnths.
                    st
       wks.at least to low. likelihood of relapse.  System.candidias.& cryptococc.infect: 6-12 mg/ kg/day de-  Candida balanitis: Adults: 150 mg as sngl.oral dos.
       Oesophag.candidiasis:  Adults: 200 mg on 1  day follow.by 100-  pend.on severity.  Derm.infects.eg.tinea pedis, corporis, cruris and candida
                           st
       200 mg once dly.with dos.of upto 400 mg dly accord.to pt.respons.   Fung.infect.prophylax.in immunocomprom. pts.at risk as a   infects: Adults: 150 mg once wkly. x2-4 wks. but up to 6 wks.
       Treat for min.3 wks. & x2 wks.aft.sympt.resolut. Childr. over 4 wks:   consequenc.of neutropen. follow.chemo/radiother: 3-12 mg/  for tinea pedis.
              st
       Init 6 mg/kg on 1  day follow.by 3 mg/kg once dly.with dos.of up to   kg dly.depend. on extent & durat.of induc.neutropen.  Tinea unguium: Adults:150 mg once wkly.x3-12 mnths until nail
       12 mg/kg/day accord.to pt.respons. Treat for min.3 wks.& x2 wks.  (S4) CAPS, [P/S] 37/20.2.2/0116  completely replac.
       aft.sympt.resolut.            Indications: Ac/recurr.vag.candidiasis & prophylax. to reduc.incid.  Children:
       Candidias.prophylax: Adults: 50-400 mg once dly. bas. on risk   of recurr.vag.candidias., candidial balanitis, dermatomycos.incl. tinea   Safety & effic has not been est.in childr.for recur. vag.candidias./can-
       profile. Pts.at high risk of system. infect. i.e. those anticipat.to have   pedis, tinea corporis, tinea cruris, tinea unguium (onychomycosis) &   dida balanit./derm.infects. incl.tinea pedis, tinea corporis, tinea cruris,
       profound/ prolong. neutropen.have receiv.400 mg once dly. Commenc.   derm. candida infects.  tinea unguium (onychomycosis) & derm.candid.infects.
       ther.sev.days bef.anticipat.neutropen & contin.x7 days aft. neutrophil   700149-001: 150 mg, 1, R28,84  Use in childr.4 wks.& younger: In 1st 2 wks.of life: Use same
                      3
       count rises above 1000 cells per mm  Childr.over 4 wks: 3-12 mg/   Dosage: Adults  mg/kg dos.as for older childr.but admin. every 72 hrs. Wks. 3-4:
       kg dly.depend.on extent & durat.of induc. neutropen.  Vag.candidiasis: 150 mg as sngl.oral dose.  Same dos.but every 48 hrs. Max.adult dos.(400 mg) should not be
       Vag.candidias: Adults: 150 mg as sngl.oral dos.  Reduc.incid.of recurr.vag.candidias: 150 mg once monthly indiv.  exceed. in childr.
       Reduc.incid.of recurr.vag.candidias: Adults: 150 mg once   durat.which range from 4-12 mnths.  Contraindications: Concom.cisapride, concom. terfenadine with
       monthly indiv.durat.which range from 4-12 mnths.  Candida balanitis: 150 mg as sngl.oral dos.  multiple fluconazole dos.&gt;400 mg / day, monit.multiple dos.ther.in
       Candida balanitis: Adults: 150 mg as sngl.oral dos.  Derm.infects.eg.tinea pedis, corporis, cruris and candida in-  ren.impairm., pregn. & breastfeed.
       Derm.infects.eg.tinea pedis, corporis, cruris and candida   fects: 150 mg once wkly.x2-4 wks. but up to 6 wks.for tinea pedis.  Side effects: GI disturbs., rash, headache, hepat. ren.& haematolog.
       infects: Adults: 150 mg once wkly. x2-4 wks. but up to 6 wks.  Tinea unguium: 150 mg once wkly.x3-12 mnths until nail com-  funct.disturbs.partic.in pts.with ser. underly.dis.such as AIDS and Ca,
       for tinea pedis.              pletely replac.              CNS effs., alopec., bld.dyscras., allerg.reacts.incl.anaphylax., hyper-</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page289.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page285.html">285</a>&nbsp;&nbsp;&nbsp;<a href="page286.html">286</a>&nbsp;&nbsp;&nbsp;<a href="page287.html">287</a>&nbsp;&nbsp;&nbsp;<a href="page288.html">288</a>&nbsp;&nbsp;&nbsp;<a href="page289.html">289</a>&nbsp;&nbsp;&nbsp;<a href="page290.html">290</a>&nbsp;&nbsp;&nbsp;<a href="page291.html">291</a>&nbsp;&nbsp;&nbsp;<a href="page292.html">292</a>&nbsp;&nbsp;&nbsp;<a href="page293.html">293</a>&nbsp;&nbsp;&nbsp;<a href="page294.html">294</a>&nbsp;&nbsp;&nbsp;<a href="page295.html">295</a>
             </td>
             <td width="35%"><a href="page291.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page291.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
